5.56
price up icon3.93%   0.21
after-market アフターアワーズ: 5.56
loading
前日終値:
$5.35
開ける:
$5.32
24時間の取引高:
869.28K
Relative Volume:
1.45
時価総額:
$218.11M
収益:
$425.17M
当期純損益:
$-92.21M
株価収益率:
556.00
EPS:
0.01
ネットキャッシュフロー:
$-67.42M
1週間 パフォーマンス:
+5.90%
1か月 パフォーマンス:
+11.87%
6か月 パフォーマンス:
-50.75%
1年 パフォーマンス:
-65.40%
1日の値動き範囲:
Value
$5.22
$5.66
1週間の範囲:
Value
$5.10
$5.71
52週間の値動き範囲:
Value
$4.382
$22.64

Nevro Corp Stock (NVRO) Company Profile

Name
名前
Nevro Corp
Name
セクター
Healthcare (1182)
Name
電話
650-251-0005
Name
住所
1800 BRIDGE PARKWAY, REDWOOD CITY, CA
Name
職員
0
Name
Twitter
@Nevro_HF10
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
NVRO's Discussions on Twitter

Nevro Corp Stock (NVRO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-01-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-12-21 ダウングレード Canaccord Genuity Buy → Hold
2023-07-19 開始されました Robert W. Baird Neutral
2023-05-31 開始されました RBC Capital Mkts Outperform
2023-05-15 アップグレード Oppenheimer Perform → Outperform
2023-04-14 開始されました Mizuho Neutral
2023-01-17 ダウングレード Citigroup Buy → Neutral
2023-01-06 ダウングレード Piper Sandler Neutral → Underweight
2022-12-20 アップグレード Canaccord Genuity Hold → Buy
2022-12-12 ダウングレード Wells Fargo Overweight → Equal Weight
2022-10-12 開始されました Jefferies Underperform
2022-05-05 アップグレード Citigroup Neutral → Buy
2022-04-13 再開されました Truist Hold
2022-04-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Underperform
2022-01-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-11-09 ダウングレード Truist Buy → Hold
2021-08-05 ダウングレード Canaccord Genuity Buy → Hold
2021-08-05 ダウングレード Citigroup Buy → Neutral
2021-08-05 ダウングレード Piper Sandler Overweight → Neutral
2021-08-05 ダウングレード Wells Fargo Overweight → Equal Weight
2021-08-05 ダウングレード William Blair Outperform → Mkt Perform
2021-07-09 ダウングレード Redburn Buy → Neutral
2021-07-06 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-02 開始されました Piper Sandler Overweight
2020-10-23 開始されました Guggenheim Buy
2020-09-02 開始されました Robert W. Baird Outperform
2020-06-08 アップグレード UBS Sell → Neutral
2020-03-05 開始されました Citigroup Buy
2020-02-26 アップグレード Canaccord Genuity Hold → Buy
2020-01-08 開始されました SunTrust Buy
2020-01-06 ダウングレード Oppenheimer Outperform → Perform
2019-11-07 アップグレード Oppenheimer Perform → Outperform
2019-10-22 開始されました Oppenheimer Perform
2019-03-20 アップグレード BofA/Merrill Neutral → Buy
2019-03-20 アップグレード Wells Fargo Market Perform → Outperform
2018-11-28 開始されました UBS Sell
2018-11-07 ダウングレード BofA/Merrill Buy → Neutral
2018-11-06 ダウングレード JP Morgan Overweight → Neutral
2018-11-06 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-10-19 ダウングレード Goldman Neutral → Sell
2018-07-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-05-08 繰り返されました Canaccord Genuity Buy
2018-05-08 ダウングレード Northland Capital Outperform → Market Perform
2018-05-08 ダウングレード Wells Fargo Outperform → Market Perform
すべてを表示

Nevro Corp (NVRO) 最新ニュース

pulisher
Nov 04, 2024

Nevro (NVRO) to Release Earnings on Monday - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Nevro (FRA:1N7) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com

Nov 03, 2024
pulisher
Nov 01, 2024

Nevro (NYSE:NVRO) Upgraded to Hold at StockNews.com - MarketBeat

Nov 01, 2024
pulisher
Oct 30, 2024

Assenagon Asset Management S.A. Increases Position in Nevro Corp. (NYSE:NVRO) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy - PR Newswire

Oct 29, 2024
pulisher
Oct 29, 2024

Nevro Corp. (NYSE:NVRO) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

President & CEO Thornal Kevin R covered exercise/tax liability with 6,063 shares, decreasing direct ownership by 2% to 249,847 units (SEC Form 4) - Quantisnow

Oct 28, 2024
pulisher
Oct 24, 2024

Chronic Pain Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | AstraZeneca, Regenacy Pharma, Nevro Corp., Erchonia Corporation - The Globe and Mail

Oct 24, 2024
pulisher
Oct 24, 2024

StockNews.com Upgrades Nevro (NYSE:NVRO) to Hold - MarketBeat

Oct 24, 2024
pulisher
Oct 18, 2024

Trading (NVRO) With Integrated Risk Controls - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Nevro announces new inducement grants - Medical Buyer

Oct 17, 2024
pulisher
Oct 16, 2024

StockNews.com Lowers Nevro (NYSE:NVRO) to Sell - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Nevro shares target cut by Baird, retains neutral stance - Investing.com Australia

Oct 16, 2024
pulisher
Oct 16, 2024

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Marketscreener.com

Oct 16, 2024
pulisher
Oct 15, 2024

Nevro Corp (NVRO) PT Lowered to $5 at Baird - StreetInsider.com

Oct 15, 2024
pulisher
Oct 12, 2024

Nevro Corp. (NYSE:NVRO) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 12, 2024
pulisher
Oct 10, 2024

Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 - BioSpace

Oct 10, 2024
pulisher
Oct 10, 2024

Millennium Management LLC Increases Holdings in Nevro Corp. (NYSE:NVRO) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Here's Why You Should Retain Nevro (NVRO) Stock for Now - MSN

Oct 09, 2024
pulisher
Oct 08, 2024

SVP, Corp Dev and CLO Rashid Kashif covered exercise/tax liability with 479 shares, decreasing direct ownership by 0.30% to 161,352 units (SEC Form 4) - Quantisnow

Oct 08, 2024
pulisher
Oct 06, 2024

Nevro obtains FDA approval for AI-based spinal cord stimulation system - MSN

Oct 06, 2024
pulisher
Oct 04, 2024

Nevro Corp. (NYSE:NVRO) Shares Purchased by Point72 Asset Management L.P. - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Nevro Corp. (NYSE:NVRO) Receives $10.55 Consensus Price Target from Brokerages - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Nevro Corp. (NYSE:NVRO) Shares Sold by Cubist Systematic Strategies LLC - MarketBeat

Oct 03, 2024
pulisher
Oct 01, 2024

Breaking Down Nevro: 10 Analysts Share Their Views - Benzinga

Oct 01, 2024
pulisher
Oct 01, 2024

Nevro (NYSE:NVRO) PT Lowered to $6.00 at Citigroup - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Nevro Corp.'s SWOT analysis: stock faces headwinds amid SCS market challenges - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Nevro Corp.'s SWOT analysis: stock faces headwinds amid SCS market challenges By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 26, 2024

Where are the Opportunities in (NVRO) - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Here's Why you Should Retain Nevro Stock in Your Portfolio Now - Yahoo Finance

Sep 26, 2024
pulisher
Sep 26, 2024

Nevro Corp. (NYSE:NVRO) Shares Sold by Fred Alger Management LLC - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform - Yahoo Finance

Sep 25, 2024
pulisher
Sep 24, 2024

Nevro wins FDA nod for AI-driven spinal cord stimulation tech - Mass Device

Sep 24, 2024
pulisher
Sep 24, 2024

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation - PR Newswire

Sep 24, 2024
pulisher
Sep 17, 2024

Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - GlobeNewswire Inc.

Sep 17, 2024
pulisher
Sep 15, 2024

Nevro Corp. (NYSE:NVRO) Stake Raised by Acadian Asset Management LLC - MarketBeat

Sep 15, 2024
pulisher
Sep 12, 2024

Vanguard Group Inc's Strategic Reduction in Nevro Corp Holdings - Yahoo Finance

Sep 12, 2024
pulisher
Sep 09, 2024

Nevro Corp. (NYSE:NVRO) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat

Sep 09, 2024
pulisher
Sep 06, 2024

Nevro (NYSE:NVRO) Share Price Passes Below 50-Day Moving Average of $7.62 - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Microelectronic Medical Implants Market Report 2024-2029, with Profiles of Leading Players, including Abbott, Biotronik, Cochlear, LivaNova, Medtronic, Neuropace and Nevro - Yahoo Finance UK

Sep 06, 2024
pulisher
Aug 31, 2024

(NVRO) Trading Report - Stock Traders Daily

Aug 31, 2024
pulisher
Aug 30, 2024

SVP, Corp Dev and CLO Rashid Kashif covered exercise/tax liability with 817 shares, decreasing direct ownership by 0.50% to 163,590 units (SEC Form 4) - Quantisnow

Aug 30, 2024
pulisher
Aug 28, 2024

Nevro to Present at Wells Fargo 2024 Healthcare Conference - The Malaysian Reserve

Aug 28, 2024
pulisher
Aug 21, 2024

Nevro (NYSE:NVRO) Lowered to "Sell" at StockNews.com - MarketBeat

Aug 21, 2024
pulisher
Aug 19, 2024

Assenagon Asset Management S.A. Has $6.13 Million Position in Nevro Corp. (NYSE:NVRO) - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

Nathan B Pliam Net Worth (2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 15, 2024

Nevro Corp. (NYSE:NVRO) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

Nevro Corp. (NYSE:NVRO) Given Average Rating of “Reduce” by Brokerages - Defense World

Aug 15, 2024

Nevro Corp (NVRO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices ZBH
$108.92
price up icon 0.47%
medical_devices STE
$227.44
price up icon 0.72%
medical_devices PHG
$27.08
price up icon 0.00%
$69.00
price down icon 1.00%
$88.17
price up icon 1.36%
medical_devices EW
$66.69
price up icon 0.33%
大文字化:     |  ボリューム (24 時間):